ijms-logo

Journal Browser

Journal Browser

Molecular Study and Treatment of Motor Neuron Diseases

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".

Deadline for manuscript submissions: 28 August 2024 | Viewed by 915

Special Issue Editors


E-Mail
Guest Editor
CNR-Istituto di Farmacologia Traslazionale, 00133 Rome, Italy
Interests: neurodegeneration; amyotrophic lateral sclerosis; RNA metabolism; RNA-binding proteins; stress response; spinal muscular atrophy; repeat expansion disorders, antisense oligonucleotides

E-Mail Website
Guest Editor
Department of Biology, Tor Vergata University of Rome, 00133 Rome, Italy
Interests: molecular mechanisms of neurodegeneration; amyotrophic lateral sclerosis; neuroinflammation; microglia; fibrosis; astrocytes; animal models of neurodegenerative diseases; purinergic signaling; histaminergic signaling; neuropharmacology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Motor neuron diseases (MNDs) are a group of progressive neurological disorders in which motor neurons undergo degeneration and death. It includes diseases such as amyotrophic lateral sclerosis (ALS), progressive bulbar palsy (PBP), primary lateral sclerosis (PLS), progressive muscular atrophy (PMA), spinal muscular atrophy (SMA), spinal and bulbar muscular atrophy (SBMA), and post-polio syndrome.

Although recent progress in neurochemical, physiological, genetic investigations has led to the identification of several cellular processes that seem to be involved in the motor neuronal degeneration, certain questions about the pathogenic mechanisms of MNDs remain unknown. Comprehension of these underlying mechanisms is of paramount importance because it can play a crucial role in the research and development of novel therapeutic strategies.

This Special Issue invites submissions of original papers and review articles that highlight the latest discoveries and advancements in the field of pathophysiological mechanisms, biomarker research and novel therapeutic targets in MND.

Dr. Simona Rossi
Dr. Savina Apolloni
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • motor neuron
  • amyotrophic lateral sclerosis
  • neuronal degeneration
  • pathogenic mechanisms
  • molecular therapy

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

17 pages, 1964 KiB  
Article
A Potential Role of Interleukin-5 in the Pathogenesis and Progression of Amyotrophic Lateral Sclerosis: A New Molecular Perspective
by Anca Moțățăianu, Sebastian Andone, Adina Stoian, Rodica Bălașa, Adina Huțanu and Emanuela Sărmășan
Int. J. Mol. Sci. 2024, 25(7), 3782; https://doi.org/10.3390/ijms25073782 - 28 Mar 2024
Viewed by 504
Abstract
Cumulative data suggest that neuroinflammation plays a prominent role in amyotrophic lateral sclerosis (ALS) pathogenesis. The purpose of this work was to assess if patients with ALS present a specific peripheral cytokine profile and if it correlates with neurological disability assessed by ALSFRS-R, [...] Read more.
Cumulative data suggest that neuroinflammation plays a prominent role in amyotrophic lateral sclerosis (ALS) pathogenesis. The purpose of this work was to assess if patients with ALS present a specific peripheral cytokine profile and if it correlates with neurological disability assessed by ALSFRS-R, the rate of disease progression, and the pattern of disease progression (horizontal spreading [HSP] versus vertical spreading [VSP]). We determined the levels of 15 cytokines in the blood of 59 patients with ALS and 40 controls. We identified a positive correlation between levels of pro-inflammatory cytokines (interleukin [IL]-17F, IL-33, IL-31) and the age of ALS patients, as well as a positive correlation between IL-12p/70 and survival from ALS onset and ALS diagnosis. Additionally, there was a positive correlation between the ALSFRS-R score in the upper limb and respiratory domain and IL-5 levels. In our ALS cohort, the spreading pattern was 42% horizontal and 58% vertical, with patients with VSP showing a faster rate of ALS progression. Furthermore, we identified a negative correlation between IL-5 levels and the rate of disease progression, as well as a positive correlation between IL-5 and HSP of ALS. To the best of our knowledge, this is the first study reporting a “protective” role of IL-5 in ALS. Full article
(This article belongs to the Special Issue Molecular Study and Treatment of Motor Neuron Diseases)
Show Figures

Figure 1

Back to TopTop